OMICS Group International is an open access online publishing group which has 700+ peer-reviewed journals, organizes 3000+ International Scientific Conferences per year, have around 50,000+ editorial board members and 1000+ Scientific associations. Medical Journals provide a platform for outstanding research around the globe in the field of medicine. These scholarly journals aim to contribute to the progress and application of scientific discoveries, by providing free access to the research information. The published work reaches the general public and the scientific community immediately after publication, thus providing higher citation rates for the author. Medical Journals are supported by 5000 internationally renowned editorial board members and a high quality review board. Medical Journals use online Editorial Manager System for quick and high quality review process. Articles of Medical journals are subjected to peer reviewing and these are included in the standard indexing databases like ISI, Scopus, EBSCO, CAS, HINARI etc. All the articles published in Medical journals are permanently archived in respective peer reviewed journals thus providing unrestricted utilization and requisition of the scientific information.
Marine microorganisms widely distributed on our oceans of the earth and emerging as the great source for the discovery of natural products. Further they are developing as therapeutic agents for various human diseases. Antibacterial, antifungal, anti-parasitic, antiviral, anti-infective, insecticidal, antitumor, antiinflammatory, antioxidant and herbicidal compounds as well as many other compounds are enzyme inhibitors have been isolating from marine actinomycetes. Marine drugs have been used as therapeutic drug for various diseases like cancer, typhoid, cholera etc, Hymenialdisine (HMD), a sponge-derived natural product reported as human kinase inhibitors with nanomolar activity. Several antitumor antibiotics like aporphine alkaloids have been isolated from marine actinomycetes. Several marine-derived compounds used as anticancer agents are undergoing promising preclinical and clinical development. Therefore, the marinederivedactinomycetes act as a prominent reservoir for novel drug molecules and answer to several diseases.(NagendraSastryYarla, Marine Actinomycetes: A Source of Novel Therapeutic Drugs)
Last date updated on November, 2020